My Recent Searches
- No Recent Search.
My Tests Viewed
- No Test Viewed.
CFvantage® Cystic Fibrosis Expanded Screen
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
The CFvantage® Cystic Fibrosis Expanded Screen analyzes mutations that have been proven to cause Cystic Fibrosis. This panel includes the 23 mutations recommended by the American College of Obstetricians and Gynecologists (ACOG) for screening of all child bearing age women. ACOG also recommends that patients with a family history of Cystic Fibrosis, pregnant women with ultrasound finding that indicate an increased risk of Cystic Fibrosis (echogenic bowel or dilated loops of the bowel), and males with a family history of infertility should be offered this screen.
Multiplex PCR • Next Generation Sequencing
See Laboratory Report
CF Mutation Screen,CFTR Expanded Mutation Screen,CF155 Mutations,Cystic Fibrosis Mutation Screen,CFTR Screen,CF Carrier Screen,CF Expanded Mutation Carrier Screen,Cystic Fibrosis Expanded Panel,Cystic Fibrosis Carrier Screen
To view specimen requirements and codes please Select a regional laboratory.
Not sure which laboratory serves your office? Call us 866-MYQUEST (866-697-8378)
Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.